Techmediabreaks Senestech Inc. (NASDAQ: SNES) Releases Q2 2024 Financial, Corporate Report

(MENAFN- Investor Brand Network) SenesTech (NASDAQ: SNES) , the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R), is reporting on its second-quarter 2024 financial results. According to the report, the company saw record revenue of $874,000
in the first half of 2024, a 62% increase when compared to the first half of 2023, as well as improvement in margin percentages.

In addition, the report noted key performance indicators, such as SenesTech's Evolve(TM) product line, which was launched this year, becoming the company's biggest-selling product line, contributing some 60% revenue this year's numbers. The report also noted that significant third-party efficacy trials have begun.

“The second-quarter results highlight yet another quarter of record top line sales,” said SenesTech president and CEO Joel Fruendt in the press release.“Sixty-two percent growth year to date versus the same period in 2023, as well as strong operational improvement of numerous key metrics have reduced our cash burn as we look to achieve our near-term objective of profitability. Importantly, we are ideally positioned to see accelerating growth due to the initiatives we put in place throughout the first half of 2024, including the launch of Evolve for rats with key online retailers; the launch of our new Evolve Mouse solution; the ramp up of recently secured distribution agreements; and new product packing options.”

To view the full press release, visit

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve and Evolve Mouse, an EPA-designated, minimum-risk contraceptive for rodents, reflecting the company's mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households - with a product designed to be humane, effective and sustainable. For more information about the company, please visit
.

NOTE TO INVESTORS:
The latest news and updates relating to SNES are available in the company's newsroom at

About TechMediaWire

TechMediaWire
(“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 60+ brands within
the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today's market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text“TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published:
/Disclaimer

TechMediaWire
Los Angeles, CA

310.299.1717 Office
...

TechMediaWire is powered by
IBN

MENAFN09082024000224011066ID1108538032